Here is Why Growth Investors Should Buy REV Group (REVG) Now — Positive
REVG Zacks Investment Research — September 25, 2025REV Group (REVG) possesses solid growth attributes, which could help it handily outperform the market.
CVS Health Gains as Revenue Grows, Dividend Remains Strong — Positive
CVS MarketBeat — September 25, 2025One of the best ways for any investor to lock in additional portfolio upside is to start exploring areas where few others are willing to venture, especially when those are the least popular ones in the entire market.
General Dynamics secures $1.5 billion IT contract for STRATCOM — Positive
GD Reuters — September 25, 2025General Dynamics said on Thursday its information technology unit has secured an enterprise modernization contract worth $1.5 billion, to help support the U.S. Strategic Command, or STRATCOM.
Oracle Bets Big on Cloud Expansion: A Sign of Strong Upside Ahead? — Positive
ORCL Zacks Investment Research — September 25, 2025ORCL's cloud revenues surge as a bold $35B data center expansion and major AI contracts fuel long-term growth ambitions.
AMD Gains Traction in AI Infrastructure Market: A Sign of More Upside? — Positive
AMD Zacks Investment Research — September 25, 2025Advanced Micro Devices' growth is driven by AI footprint with record sales, new Instinct MI350 GPUs and major partnerships.
Deadline Alert: Novo Nordisk A/S (NVO) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit — Neutral
NVO GlobeNewsWire — September 25, 2025LOS ANGELES, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming September 30, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Novo Nordisk A/S (“Novo Nordisk” or the “Company”) (NYSE: NVO) securities between May 7, 2025, to July 28, 2025, inclusive (the “Class Period”).
Vertex Pharmaceuticals: Trikafta And Alyftrek Cement Market Leadership — Positive
VRTX Seeking Alpha — September 25, 2025Even amid political pressure from RFK Jr. and President Trump, as well as failed clinical data on VX-993, Vertex continues to strengthen its position in the cystic fibrosis market. Sales of its three key drugs, Trikafta, Kaftrio, and Alyftrek, which are part of the CF portfolio, reached about $2.71 billion in the second quarter of 2025, up 10.6% year-on-year. On the positive side, Vertex's operating income margin, which was 38.9% for the three months ended June 30, 2025, is higher than that of its competitors, including Pfizer and Sarepta.
Can Disney's Hulu-Disney+ Integration Lift ARPU and Boost Retention? — Positive
DIS Zacks Investment Research — September 25, 2025DIS' Hulu integration into Disney+ aims to cut costs, boost ARPU and strengthen subscriber retention while driving sustainable revenue growth.
RTX Wins a Contract for F135 Propulsion System in Support of F-35 Jets — Positive
RTX Zacks Investment Research — September 25, 2025RTX secures a $60M deal to supply F135 propulsion systems for F-35 jets, supporting U.S. forces and global partners through 2027.
Kinetic Completes Future-Proof Fiber-Optic Network in Ruidoso — Neutral
UNIT GlobeNewsWire — September 25, 2025RUIDOSO, N.M., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Local residential and business fiber internet service provider Kinetic, the Ruidoso Valley Chamber of Commerce, and New Mexico state officials gathered today for a ribbon-cutting ceremony to commemorate the completion of Kinetic's brand-new, fiber-optic network in Ruidoso, which underscores the company's long-term commitment to the community.
Tesla urges Trump not to repeal vehicle emissions rules, climate finding — Neutral
TSLA Reuters — September 25, 2025Electric vehicle manufacturer Tesla urged the Trump administration not to repeal vehicle emissions standards or the long-standing U.S. finding that greenhouse gas emissions endanger human health.
Axon to Expand Public Safety Platform With Prepared Acquisition — Positive
AXON Zacks Investment Research — September 25, 2025AXON moves to acquire AI-powered emergency communications firm Prepared, aiming to boost its public safety platform.
More Defense Spending Will Drive Critical Minerals Demand — Positive
SETM ETF Trends — September 25, 2025With the United States becoming less involved in NATO affairs, it's forcing European nations to become more reliant in bolstering their defensive capabilities. This leads to increased defense spending, which could drive up demand for critical minerals.
Amazon cuts $2.5B settlement with FTC over allegedly trapping customers in Prime subscriptions — Neutral
AMZN New York Post — September 25, 2025Amazon has agreed to a massive $2.5 billion settlement with the Federal Trade Commission over charges that it knowingly trapped customers into paying for Prime subscriptions, the agency announced Thursday.
Should Apple buy Intel's stock? These analysts suggest a better investment. — Neutral
AAPL INTC Market Watch — September 25, 2025Intel reportedly approached Apple about an investment, but absent “obvious benefits” to the smartphone giant, some analysts say the company would be better off just repurchasing more of its own stock.
Deadline Alert: SelectQuote, Inc. (SLQT) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit — Neutral
SLQT GlobeNewsWire — September 25, 2025LOS ANGELES, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming October 10, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired SelectQuote, Inc. (“SelectQuote” or the “Company”) (NYSE: SLQT) securities between September 9, 2020 and May 1, 2025, inclusive (the “Class Period”).
LEU Unveils Bold Expansion Plans: Solid Roadmap Ahead? — Positive
LEU Zacks Investment Research — September 25, 2025Centrus Energy plans a major expansion of its Ohio plant to boost LEU and HALEU output, backed by expected billions in funding and global partnerships.
Should Investors Increase Their Allocation to U.K. ETFs Now? — Neutral
EWU EWUS FKU FLGB Zacks Investment Research — September 25, 2025The U.K. sees mixed signals: slowing growth and easing inflation, but a $150B U.S. deal could spark investor optimism.
ROSEN, THE FIRST FILING FIRM, Encourages KBR, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – KBR — Neutral
KBR GlobeNewsWire — September 25, 2025NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of KBR, Inc. (NYSE: KBR) between May 6, 2025 and June 19, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 18, 2025 in the securities class action first filed by the Firm.
Theratechnologies Announces Completion of Acquisition by Future Pak — Neutral
THTX GlobeNewsWire — September 25, 2025MONTREAL, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, announced today the completion of the previously-announced plan of arrangement under Chapter XVI – Division II of the Business Corporations Act (Québec) involving CB Biotechnology, LLC (the “Purchaser”), an affiliate of Future Pak, LLC (“Future Pak”), pursuant to which the Purchaser has acquired all the issued and outstanding common shares of the Company (the "Shares") for US$3.01 per Share in cash plus one contingent value right (“CVR”) per Share for additional aggregate cash payments of up to US$1.19 per …